article thumbnail

Drug developers look at innovative mechanisms to tackle dry eye syndrome

Pharmaceutical Technology

Dry eye syndrome (DES) is an indication whose mainstay treatment has been dominated by Allergan’s Restasis (cyclosporine ophthalmic emulsion 0.05%) ever since its launch in 2003 in the US. Current treatment options for DES are dominated by a mix of prescription and over-the-counter (OTC) products.

article thumbnail

A Primer on Telepharmacy

Nixon Gwilt Law

And that’s because pharmacy is an incredibly important part of the healthcare ecosystem—for many patients, they see their pharmacist far more often than their primary care physician. Due to the success of the North Dakota Telepharmacy Project, the Board of Pharmacy in North Dakota permanently implemented telepharmacy regulations in 2003.

Medical 52